Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) — Cash Flow Quality Index
Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) has a Cash Flow Quality Index of -1.00x as of December 2024. Operating cash flow of CN¥-60.52 Million is below net income of CN¥60.45 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore balance sheet size of Shandong Keyuan Pharmaceutical Co. Ltd. for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shandong Keyuan Pharmaceutical Co. Ltd. A Cash Flow Quality Index (2021–2024)
Historical Cash Flow Quality Index for Shandong Keyuan Pharmaceutical Co. Ltd. A across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Shandong Keyuan Pharmaceutical Co. Ltd. tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Shandong Keyuan Pharmaceutical Co. Ltd. A (2021–2024)
Year-by-year earnings quality comparison for Shandong Keyuan Pharmaceutical Co. Ltd. A. For live market cap and the full company financial profile, see how much is Shandong Keyuan Pharmaceutical Co. Ltd. worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -1.00x | CN¥-60.52 Million | CN¥60.45 Million | ▼ -308.3% |
| 2023 | 0.48x | CN¥37.03 Million | CN¥77.04 Million | ▼ -62.1% |
| 2022 | 1.27x | CN¥115.86 Million | CN¥91.28 Million | ▲ +90.7% |
| 2021 | 0.67x | CN¥52.02 Million | CN¥78.17 Million | — |